GlassScriptPhysician profile
Faris M Murad
NPI 1205970563
$11,435.44
in general payments reported to CMS, 2019-2025
17 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,428 · 2020: $266 · 2021: $263 · 2022: $598 · 2023: $6,695 · 2024: $78.96 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850 · Travel and Lodging: $3,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,849.98 |
| Travel and Lodging | $3,030.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Creo Medical INC. | $6,185.70 | 2022-2023 | Speedboat |
| Aries Pharmaceuticals, INC. | $3,187.64 | 2019 | |
| Conmed Corporation | $412.09 | 2021-2023 | Airseal, Conmed Biliary |
| Endogastric Solutions, INC | $358.59 | 2019-2023 | Esophyx |
| Cook Medical LLC | $296.72 | 2020-2023 | Hemospray |
| Boston Scientific Corporation | $281.93 | 2022-2024 | Exalt Model D |
| Apollo Endosurgery US INC | $257.77 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Abbvie INC. | $128.37 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $82.53 | 2019-2025 | Xifaxan |
| Janssen Biotech, INC. | $71.89 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $45.52 | 2020-2021 | |
| Qol Medical, LLC | $42.04 | 2020 | |
| Olympus Corporation of The Americas | $24.80 | 2019 | |
| Novo Nordisk INC | $17.80 | 2025 | Wegovy |
| Evoke Pharma, INC. | $14.89 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $14.73 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faris Murad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.